Becton Dickinson & Co (NYSE:BDX)
$ 221.9 -0.08 (-0.04%) Market Cap: 64.16 Bil Enterprise Value: 82.13 Bil PE Ratio: 37.36 PB Ratio: 2.48 GF Score: 85/100

Becton Dickinson and Co at Wells Fargo Virtual Healthcare Conference Transcript

Sep 09, 2021 / 12:00PM GMT
Release Date Price: $253.63 (-1.04%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

All right. Good morning, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. I'm pleased to have BD kick off the first day of our 2021 Virtual Healthcare Conference. Very, very sorry about the technical glitches Hopefully, the rest of the day will go more smoothly.

Joining us from the company are the President and CEO, Tom Polen; the new CFO, Chris DelOrefice. And somewhere in the background is Kristen Stewart, Vice President of Strategy and Investor Relations.

In terms of format, it was supposed to be a 30-minute fireside chat, but I think it's down to 13 minutes now. So Tom and Chris are going to have to speak very quickly to get in all my questions. We were also going to do a polling question, but we're going to skip that, given the time constraint. So Tom, Chris and Kristen, thanks a lot for being here.

Christopher DelOrefice
Becton, Dickinson and Company - Executive VP & CFO

Thanks, Larry. Good

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot